Detection of fetal red cells in fetomaternal hemorrhage using a fetal hemoglobin monoclonal antibody by flow cytometry

BACKGROUND: The laboratory determination of the level of fetal cells in maternal circulation remains an important support in the obstetrical management of women with suspected uterine trauma and in the proper dose administration of anti‐D for prevention of Rh hemolytic disease of the newborn. Limita...

Full description

Saved in:
Bibliographic Details
Published inTransfusion (Philadelphia, Pa.) Vol. 38; no. 8; pp. 749 - 756
Main Authors Davis, B.H., Olsen, S., Bigelow, N.C., Chen, JC
Format Journal Article
LanguageEnglish
Published Edinburgh, UK Blackwell Science Ltd 01.08.1998
Blackwell Publishing
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BACKGROUND: The laboratory determination of the level of fetal cells in maternal circulation remains an important support in the obstetrical management of women with suspected uterine trauma and in the proper dose administration of anti‐D for prevention of Rh hemolytic disease of the newborn. Limitations in the sensitivity and precision of the widely used manual Kleihauer‐Betke test have prompted an increased utilization of flow cytometric methods for fetal cell detection in maternal blood samples. STUDY DESIGN AND METHODS:Murine monoclonal antibodies directed against fetal hemoglobin (HbF) were developed, conjugated to fluorescein isothiocyanate, and used in a multiparametric flow cytometric assay developed for the quantitation of fetal red cells. A rapid intracellular staining method using brief glutaraldehyde fixation and Triton X‐100 permeabilization prior to monoclonal antibody incubation was developed, along with optimization of the flow cytometric analysis protocol for the analysis of 50,000 cells. The performance of the assay was assessed for linearity and precision and correlated with the Kleihauer‐Betke acid elution method. RESULTS:The anti‐HbF flow cytometric method showed good correlation with the Kleihauer‐Betke method (r2 = 0.86) and superior precision with a CV < 15 percent for blood samples with > 0.1 percent fetal cells. Analysis of 150 blood samples from nonpregnant adults, including individuals with elevated HbF due to hemoglobinopathies and hereditary persistence of HbF, gave a mean value of 0.02 percent fetal cells, and all results were less than 0.1 percent. CONCLUSIONS:The anti‐HbF flow cytometric method for detection of fetal cells offers a simple, reliable, and more precise alternative to the Kleihauer‐Betke manual technique for the assessment of fetomaternal hemorrhage. The method has additional potential applications for the study of HbF levels or frequency of adult red cells with low levels of HbF (F cells) in individuals with hemoglobinopathies.
Bibliography:istex:1BB9781634DC9578A734802707873746853DAB0F
ArticleID:TRF3871
ark:/67375/WNG-44NJVH17-9
Nancy C. Bigelow, BS, Research Assistant, Department of Clinical Pathology, William Beaumont Hospital.
Stephen Olsen, BS, Research Assistant, Department of Clinical Pathology, William Beaumont Hospital.
Jenn C. Chen, PhD, Cellular Immunologist, Department of Clinical Pathology, William Beaumont Hospital.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-1132
1537-2995
DOI:10.1046/j.1537-2995.1998.38898375514.x